Primary Immunodeficiency Therapeutics Market 2024-2028
Quick Buy buy_cart
Overview Scope Companies Subscription
overview_1
Incremental Growth2024-2028 (US$mn)

$ 1699.5

overview_2
2024 Year-over-Year Growth

4.23%

overview_3
CAGR (2024-2028)

4.5%

overview_4
Report Coverage

Global

Primary Immunodeficiency Therapeutics Market Segmentation

Market Segmentation & Scope
Disease Type
Antibody deficiency Cellular immunodeficiency Innate immune disorders

Geography

Europe

UK France Germany

APAC

China India Japan South Korea

North America

US Canada

South America

Brazil

Middle East and Africa

UAE

Market Segment by Geographic Landscape

regional_img

38%

of the growth will originate

from Europe

Global Market Size 2018 - 2028 (US$ Mn)

Market is segmented by Disease Type into Antibody deficiency, Cellular immunodeficiency, Innate immune disorders

The Antibody deficiency is expected to be largest growing segment during 2024-2028

Largest Segment - Antibody deficiency

US$ 13,012.70 Mn

Primary Immunodeficiency Therapeutics Market by Disease Type into Antibody deficiency; 2018-2028 (US$ Mn)

Antibody deficiency Market Revenue and Forecast 2018-2028 (US$ Mn)

Antibody deficiency

  • Antibody deficiency Market Size and Forecast 2018 to 2028 (US$ Mn)

Primary Immunodeficiency Therapeutics Market by Disease Type into Cellular immunodeficiency; 2018-2028 (US$ Mn)

Cellular immunodeficiency Market Revenue and Forecast 2018-2028 (US$ Mn)

Cellular immunodeficiency

  • Cellular immunodeficiency Market Size and Forecast 2018 to 2028 (US$ Mn)

Primary Immunodeficiency Therapeutics Market by Disease Type into Innate immune disorders; 2018-2028 (US$ Mn)

Innate immune disorders Market Revenue and Forecast 2018-2028 (US$ Mn)

Innate immune disorders

  • Innate immune disorders Market Size and Forecast 2018 to 2028 (US$ Mn)

Regional share of different regions, including

Region 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 CAGR (%)
North America 2581.90 XX XX XX XX XX XX XX XX XX XX XX
Europe XX 1777.70 XX XX XX XX XX XX XX XX XX XX
Asia XX XX 1210.00 XX XX XX XX XX XX XX XX XX
Total XX XX XX 6351.60 6635.90 XX XX XX XX XX XX XX
ROW XX XX XX XX XX XX XX XX XX XX XX XX

Primary Immunodeficiency Therapeutics Market Size by Geography into North America; 2018-2028 (US$ Mn)

North America Market Revenue and Forecast 2018-2028 (US$ Mn)

Primary Immunodeficiency Therapeutics Market Size by Country into Canada; 2018-2028 (US$ Mn)

Canada Market Revenue and Forecast 2018-2028 (US$ Mn)

Primary Immunodeficiency Therapeutics Market Size by Country into US; 2018-2028 (US$ Mn)

US Market Revenue and Forecast 2018-2028 (US$ Mn)

Primary Immunodeficiency Therapeutics Market Size by Geography into Europe; 2018-2028 (US$ Mn)

Europe Market Revenue and Forecast 2018-2028 (US$ Mn)

Primary Immunodeficiency Therapeutics Market Size by Country into Germany; 2018-2028 (US$ Mn)

Germany Market Revenue and Forecast 2018-2028 (US$ Mn)

Primary Immunodeficiency Therapeutics Market Size by Country into UK; 2018-2028 (US$ Mn)

UK Market Revenue and Forecast 2018-2028 (US$ Mn)

Primary Immunodeficiency Therapeutics Market Size by Geography into Asia; 2018-2028 (US$ Mn)

Asia Market Revenue and Forecast 2018-2028 (US$ Mn)

Primary Immunodeficiency Therapeutics Market Size by Country into China; 2018-2028 (US$ Mn)

China Market Revenue and Forecast 2018-2028 (US$ Mn)

Primary Immunodeficiency Therapeutics Market Size by Geography into Total; 2018-2028 (US$ Mn)

Total Market Revenue and Forecast 2018-2028 (US$ Mn)

Primary Immunodeficiency Therapeutics Market Size by Geography into ROW; 2018-2028 (US$ Mn)

ROW Market Revenue and Forecast 2018-2028 (US$ Mn)

Major Companies

Market Companies

Name Profile Employees Headquarters Website
ADMA Biologics Inc.View Profiletable_profile101-250Santa Clara, California, United States, North Americaavinetworks.com
Astellas Pharma Inc.View Profiletable_profile101-250Santa Clara, California, United States, North Americaavinetworks.com
Baxter International Inc.View Profiletable_profile101-250Santa Clara, California, United States, North Americaavinetworks.com
Bayer AGView Profiletable_profile101-250Santa Clara, California, United States, North Americaavinetworks.com
Bio Products Laboratory Ltd.View Profiletable_profile101-250Santa Clara, California, United States, North Americaavinetworks.com
Biocon Ltd.View Profiletable_profile101-250Santa Clara, California, United States, North Americaavinetworks.com
Biotest AGView Profiletable_profile101-250Santa Clara, California, United States, North Americaavinetworks.com
CSL Ltd.View Profiletable_profile101-250Santa Clara, California, United States, North Americaavinetworks.com
Grifols SAView Profiletable_profile101-250Santa Clara, California, United States, North Americaavinetworks.com
Kedrion SpaView Profiletable_profile101-250Santa Clara, California, United States, North Americaavinetworks.com
LFB SAView Profiletable_profile101-250Santa Clara, California, United States, North Americaavinetworks.com
Lupin Ltd.View Profiletable_profile101-250Santa Clara, California, United States, North Americaavinetworks.com
Octapharma AGView Profiletable_profile101-250Santa Clara, California, United States, North Americaavinetworks.com
Pfizer Inc.View Profiletable_profile101-250Santa Clara, California, United States, North Americaavinetworks.com
SanquinView Profiletable_profile101-250Santa Clara, California, United States, North Americaavinetworks.com
Takeda Pharmaceutical Co. Ltd.View Profiletable_profile101-250Santa Clara, California, United States, North Americaavinetworks.com

Primary Immunodeficiency Therapeutics Market Scope

  1. By Disease Type
    1. Introduction / Key Findings
    2. Historical Market Size Value (US$ million) Analysis By Disease Type, 2018 to 2022
    3. Current and Future Market Size Value (US$ million) Analysis and Forecast By Disease Type, 2024 to 2028
      1. Antibody deficiency
      2. Cellular immunodeficiency
      3. Innate immune disorders
    4. Y-o-Y Growth Trend Analysis By Disease Type, 2018 to 2022
    5. Absolute $ Opportunity Analysis By Disease Type, 2024 to 2028
  2. By Region
    1. Introduction / Key Findings
    2. Historical Market Size Value (US$ million) Analysis By Region, 2018 to 2022
    3. Current and Future Market Size Value (US$ million) Analysis and Forecast By Region, 2024 to 2028
      1. North America
      2. Europe
      3. Asia
      4. Rest of World (ROW)
  3. North America Market Analysis 2018 to 2022 and Forecast 2024 to 2028, By Country
    1. Historical Market Size Value (US$ million) Trend Analysis By Market, 2018 to 2022
    2. Market Size Value (US$ million) Forecast By Market, 2024 to 2028
    3. By Country
      1. Canada
      2. US
    4. By Disease Type
  4. Europe Market Analysis 2018 to 2022 and Forecast 2024 to 2028, By Country
    1. Historical Market Size Value (US$ million) Trend Analysis By Market, 2018 to 2022
    2. Market Size Value (US$ million) Forecast By Market, 2024 to 2028
    3. By Country
      1. Germany
      2. UK
    4. By Disease Type
  5. Asia Market Analysis 2018 to 2022 and Forecast 2024 to 2028, By Country
    1. Historical Market Size Value (US$ million) Trend Analysis By Market, 2018 to 2022
    2. Market Size Value (US$ million) Forecast By Market, 2024 to 2028
    3. By Country
      1. China
    4. By Disease Type
  6. Rest of World (ROW) Market Analysis 2018 to 2022 and Forecast 2024 to 2028, By Country
    1. Historical Market Size Value (US$ million) Trend Analysis By Market, 2018 to 2022
    2. Market Size Value (US$ million) Forecast By Market, 2024 to 2028
    3. By Disease Type

Major Companies

Market companies

Name Profile Employees Headquarters Website
ADMA Biologics Inc.View Profiletable_profile101-250Santa Clara, California, United States, North Americaavinetworks.com
Astellas Pharma Inc.View Profiletable_profile101-250Santa Clara, California, United States, North Americaavinetworks.com
Baxter International Inc.View Profiletable_profile101-250Santa Clara, California, United States, North Americaavinetworks.com
Bayer AGView Profiletable_profile101-250Santa Clara, California, United States, North Americaavinetworks.com
Bio Products Laboratory Ltd.View Profiletable_profile101-250Santa Clara, California, United States, North Americaavinetworks.com
Biocon Ltd.View Profiletable_profile101-250Santa Clara, California, United States, North Americaavinetworks.com
Biotest AGView Profiletable_profile101-250Santa Clara, California, United States, North Americaavinetworks.com
CSL Ltd.View Profiletable_profile101-250Santa Clara, California, United States, North Americaavinetworks.com
Grifols SAView Profiletable_profile101-250Santa Clara, California, United States, North Americaavinetworks.com
Kedrion SpaView Profiletable_profile101-250Santa Clara, California, United States, North Americaavinetworks.com
LFB SAView Profiletable_profile101-250Santa Clara, California, United States, North Americaavinetworks.com
Lupin Ltd.View Profiletable_profile101-250Santa Clara, California, United States, North Americaavinetworks.com
Octapharma AGView Profiletable_profile101-250Santa Clara, California, United States, North Americaavinetworks.com
Pfizer Inc.View Profiletable_profile101-250Santa Clara, California, United States, North Americaavinetworks.com
SanquinView Profiletable_profile101-250Santa Clara, California, United States, North Americaavinetworks.com
Takeda Pharmaceutical Co. Ltd.View Profiletable_profile101-250Santa Clara, California, United States, North Americaavinetworks.com
Click to Unlock the Companies Ranking
technavio-report-thumb
Start your Subscription Today!
Gain Instant Access to 21000+ Market Research Reports!
Start your Subscription